ZEB1 and ovarian carcinoma: A study by Cui et al. showed that downregulation of ZEB1 can effectively decrease the proliferative and invasive capacities of SKOV3/DPP cisplatin-resistant ovarian cancer cells upon cisplatin treatment and that in vivo downregulation of this miRNA effectively decreases the tumor volume and weight of nude mice [43].